14-99510312-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001099402.2(CCNK):āc.1273C>Gā(p.Pro425Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000016 in 1,564,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000053 ( 0 hom., cov: 25)
Exomes š: 0.000012 ( 0 hom. )
Consequence
CCNK
NM_001099402.2 missense
NM_001099402.2 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 5.32
Genes affected
CCNK (HGNC:1596): (cyclin K) The protein encoded by this gene is a member of the transcription cyclin family. These cyclins may regulate transcription through their association with and activation of cyclin-dependent kinases (CDK) that phosphorylate the C-terminal domain (CTD) of the large subunit of RNA polymerase II. This gene product may play a dual role in regulating CDK and RNA polymerase II activities. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.078762025).
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCNK | NM_001099402.2 | c.1273C>G | p.Pro425Ala | missense_variant | 11/11 | ENST00000389879.9 | NP_001092872.1 | |
CCDC85C | NM_001144995.2 | c.*4934G>C | 3_prime_UTR_variant | 6/6 | ENST00000380243.9 | NP_001138467.1 | ||
CCNK | XM_005268154.5 | c.1273C>G | p.Pro425Ala | missense_variant | 11/11 | XP_005268211.1 | ||
CCNK | XM_047431839.1 | c.1273C>G | p.Pro425Ala | missense_variant | 12/12 | XP_047287795.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCNK | ENST00000389879.9 | c.1273C>G | p.Pro425Ala | missense_variant | 11/11 | 5 | NM_001099402.2 | ENSP00000374529 | P1 | |
CCDC85C | ENST00000380243.9 | c.*4934G>C | 3_prime_UTR_variant | 6/6 | 5 | NM_001144995.2 | ENSP00000369592 | P1 | ||
CCNK | ENST00000555049.5 | c.1117+3165C>G | intron_variant | 1 | ENSP00000452307 | |||||
CCNK | ENST00000553865.1 | n.4425C>G | non_coding_transcript_exon_variant | 5/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000534 AC: 8AN: 149932Hom.: 0 Cov.: 25
GnomAD3 genomes
AF:
AC:
8
AN:
149932
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000229 AC: 5AN: 217936Hom.: 0 AF XY: 0.0000252 AC XY: 3AN XY: 119114
GnomAD3 exomes
AF:
AC:
5
AN:
217936
Hom.:
AF XY:
AC XY:
3
AN XY:
119114
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000120 AC: 17AN: 1414930Hom.: 0 Cov.: 29 AF XY: 0.0000128 AC XY: 9AN XY: 703782
GnomAD4 exome
AF:
AC:
17
AN:
1414930
Hom.:
Cov.:
29
AF XY:
AC XY:
9
AN XY:
703782
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000533 AC: 8AN: 150036Hom.: 0 Cov.: 25 AF XY: 0.0000683 AC XY: 5AN XY: 73260
GnomAD4 genome
AF:
AC:
8
AN:
150036
Hom.:
Cov.:
25
AF XY:
AC XY:
5
AN XY:
73260
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.1273C>G (p.P425A) alteration is located in exon 11 (coding exon 10) of the CCNK gene. This alteration results from a C to G substitution at nucleotide position 1273, causing the proline (P) at amino acid position 425 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Pathogenic
D
Sift4G
Uncertain
T
Polyphen
B
Vest4
MutPred
Gain of catalytic residue at P420 (P = 5e-04);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at